ONWARD Medical Announces Board Appointment
In exciting news for the medical technology sector, ONWARD Medical N.V. has officially appointed Lucas Buchanan to its Board of Directors. This strategic move underscores the company's commitment to pioneering innovative therapies designed to restore movement and independence for individuals affected by spinal cord injuries (SCI) and other mobility challenges.
Lucas Buchanan's Impressive Background
Buchanan is recognized for his invaluable experience as the former Chief Financial Officer and Chief Operating Officer at Silk Road Medical. He played a significant role in steering the company through its growth phase, which culminated in a successful acquisition by Boston Scientific. His extensive background in medical devices uniquely positions him to add significant value to ONWARD Medical.
A Proven Track Record in Medical Technology
Before his tenure at Silk Road Medical, Buchanan distinguished himself as a venture capitalist with the Vertical Group. His diverse portfolio includes roles as an investor, advisor, and board member for various progressive medical device companies and healthcare investment funds. This blend of operational and financial expertise lays a promising foundation for his contributions to ONWARD Medical.
Words from Leadership
Reflecting on Buchanan’s appointment, Dave Marver, CEO of ONWARD Medical, expressed enthusiasm by stating, "We are delighted to welcome Lucas Buchanan to our Board of Directors. His distinctive blend of experience as an operator and investor, with a history of scaling medical technology companies, aligns perfectly with our strategic growth plans." This sentiment highlights the potential for enhanced collaboration and innovation under Buchanan’s guidance.
ONWARD Medical's Vision
Buchanan himself commented on the company’s mission, declaring, "ONWARD is a truly unique company powered by an inspiring vision and groundbreaking technology. I look forward to working with Dave and the team in advancing our goals for the benefit of millions worldwide." Such an exciting collaboration hints at significant advancements to come for the company.
Decades of Experience in Commercialization
With over 25 years in the medical field, Buchanan's expertise spans commercialization, operations, and business development within the medical landscape. His leadership at Silk Road Medical was instrumental in navigating the company’s path from inception to its 2019 initial public offering and subsequent acquisition by Boston Scientific in 2024. Such insights will certainly be an asset for ONWARD Medical.
Current Roles and Education
Beyond his new role, Buchanan continues to be an active investor and serves on the boards of several medical technology firms, including influential names like Element Science and Endologix. He holds a Bachelor of Arts in Economics from Duke University and an MBA in Health Care Management from The Wharton School of the University of Pennsylvania, equipping him with the knowledge essential for navigating the complexities of healthcare innovation.
About ONWARD Medical
ONWARD Medical stands at the forefront of neurotechnology, working diligently to create therapies aimed at restoring movement and independence for those impacted by spinal cord injuries and various mobility impairments. The company has established itself as a leader in the sector, further supported by over a decade of scientific exploration and clinical research at top medical institutions.
Innovations and Products
One of ONWARD Medical’s notable developments is the ARC Therapy, which has earned Breakthrough Device Designations from the FDA. Additionally, the ARC-EX System is now commercially available in the US, and further studies are being undertaken on an investigational implantable system known as ARC-IM, with extensive research underway to develop an integrated brain-computer interface (BCI).
Global Presence
Headquartered in the Netherlands, ONWARD Medical also operates a Science and Engineering Center in Switzerland, along with an office in the United States. Furthermore, the company's shares are traded on Euronext exchanges and can also be found in the US via their American Depository Receipts under the ticker ONWRY.
Contact Information
For more inquiries regarding ONWARD Medical’s advancements and opportunities in the spinal cord injury community, individuals may contact:
Media Inquiries:
Sébastien Cros, VP Communications
Email: media@onwd.com
Investor Inquiries:
Email: investors@onwd.com
Frequently Asked Questions
What is the role of Lucas Buchanan at ONWARD Medical?
Lucas Buchanan has been appointed as a non-executive member of the Board of Directors, bringing valuable experience from his previous role as CFO and COO of Silk Road Medical.
What is ONWARD Medical known for?
ONWARD Medical is recognized for its cutting-edge neurotechnology, specifically for developing therapies aimed at restoring movement for individuals with spinal cord injuries.
What significant product has ONWARD Medical developed?
The company has developed ARC Therapy, which has received multiple Breakthrough Device Designations from the FDA.
Where is ONWARD Medical headquartered?
The company is headquartered in the Netherlands, with additional operations in Switzerland and an office located in Boston, Massachusetts.
How can interested parties learn more about ONWARD Medical?
Individuals can seek more information by contacting the company directly via their media or investor contact emails provided above.
